Marc DiSabella, Child Neurology Division |Associate Chief of Neurology Operations | Director, Headache Program | Medical Director, Neurology Education |Associate Professor of Pediatrics and Child Neurology

Financial relationships

  • Type of financial relationship:
    Other
    Ineligible company:
    Amgen
    Topic:
    Primary investigator for clinical trial
    Date added:
    10/24/2024
    Date updated:
    10/24/2024
  • Type of financial relationship:
    Other
    Ineligible company:
    Lundbeck
    Topic:
    Primary investigator for clinical trial
    Date added:
    10/24/2024
    Date updated:
    10/24/2024
  • Type of financial relationship:
    Other
    Ineligible company:
    Biohaven/Pfizer
    Topic:
    Primary investigator for clinical trial
    Date added:
    10/24/2024
    Date updated:
    10/24/2024
Return to Hot Topics in Pediatrics 2025